Benchmark

Viacom (NASDAQ: VIA) revenues came in flat at $3.3 billion, below consensus of $3.4 billion. Benchmark analysts said, "Viacom stock trades at 10x our 2011E EPS of $3.25, below a market multiple which is 12x assuming $91 of S&P 500 Index 2011E EPS. Viacom also trades at 7x 2011E EBITDA/OIBDA....

Orbitz Worldwide, Inc. (NYSE: OWW) is seeing results from the ongoing recovery in travel demand as seen by the 7% increase on travel spending in May 2010, causing Benchmark to increase its full year U.S. online travel spending forecast to 6% over 5%. Corporate travel and domestic online spending on...

Analysts at Benchmark maintain their "buy" rating on SBA Communications Corp (NASDAQ: SBAC). The target price for SBAC is set to $40. According to Benchmark, SBA Communications reported solid results for Q2. Benchmark says. “SBA meaningfully accelerated its stock buyback, purchasing 2.6 million...

Expedia, Inc. (NASDAQ: EXPE) is expected to continue gaining market share through worldwide travel recovery via discounted prices, advertising that allowed its Advertising and Media revenue to grow 39% y/y, according to Benchmark. Expedia reported 10% y/y increase in transaction volume in its 2Q,...

According to Benchmark, Yahoo! Inc. (NASDAQ: YHOO) has reported soft 2Q results due to a slowdown by large advertisers in June and low operating income before depreciation and amortization, which is down 11% y/y. Benchmark has reduced its estimates and dropped the price target from $18 to $16 per...

Analysts at Benchmark reiterate their "buy" rating on Expedia (NASDAQ: EXPE). The target price for EXPE is set to $31. EXPE is scheduled to report its Q2 earnings after the market closes on July 29. According to Benchmark, Expedia “could show 17% y/y gross bookings growth in 2Q10, leading to 9% y/...

Abraxis Bioscience Inc (NASDAQ: ABII) shares made a new high of $75.07, before slipping to $74.93, reflecting a gain of 0.17%. Within 24 hours of Celgene announcing its $2.9 billion offer for ABII, an investor has filed a lawsuit against Abraxis, alleging breach of fiduciary duty by some board of...

Google’s (NASDAQ: GOOG) license to operate its website in China has recently been renewed. On the same day, analyst Clayton Moran of Benchmark Co reiterated his “buy” rating on GOOG’s stock. He also maintained his price target for Google, owner of the world's most-used search engine, at $600. In...

With Google Inc. (NASDAQ: GOOG) expected to report 2Q2010 results Thursday, July 15, Benchmark published a research note on the tech company expecting enormous numbers: $4.9 billion in revenue (up 20% y-o-y) and adjusted EPS of $6.18. Search volumes were up 9& domestically and 19%...

Benchmark Equity research demoted Terremark Worldwide Inc. (NASDAQ: TMRK) to a Hold rating based on their valuation and the company’s relative performance. The company's shares have recently been outperforming the broader market. Benchmark now believes that this relative outperformance is unlikely...

Benchmark reduced Amazon.com's (NASDAQ: AMZN) target price 16%, from $180 to $151, reflecting on the weakness of the Euro against the dollar and slowdown in the European market. Amazon's North American sales are still strong, and could reach 33% y/y growth in 2010. Benchmark analysts Frederick...

Analysts at Benchmark upgrade Marchex Inc (NASDAQ: MCHX) from "sell" to "hold." The target price for MCHX is set to $4. According to Benchmark, domestic online advertising is showing solid recovery. “We believe the secular shift from offline to online is accelerating… While we were disappointed in...

Analysts at Benchmark reiterate their "hold" rating on Savvis Inc (NASDAQ: SVVS). The target price for SVVS is set to $20. Savvis announced last week that it has decided to acquire Fusepoint, a Canadian datacenter company in a deal worth “$125 million in cash, financed from cash reserves of $146...

Analysts at Benchmark upgrade BRE Properties (NYSE: BRE) from "hold" to "buy." The target price for BRE is set to $47. BRE’s shares gained 0.05% to close at $39.31 yesterday. More Analyst Ratings here